Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient
- 24 June 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 100 (6) , 83S-89S
- https://doi.org/10.1016/s0002-9343(96)00113-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patientsJournal of Antimicrobial Chemotherapy, 1993
- Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis modelJournal of Antimicrobial Chemotherapy, 1992
- More extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1991
- Vancomycin Added to Empirical Combination Antibiotic Therapy for Fever in Granulocytopenic Cancer PatientsThe Journal of Infectious Diseases, 1991
- -Lactam-Resistant Enterobacter Bacteremia in Febrile Neutropenic Patients Receiving MonotherapyThe Journal of Infectious Diseases, 1990
- Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patientsAntimicrobial Agents and Chemotherapy, 1990
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1990
- From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverThe Journal of Infectious Diseases, 1990
- Susceptibility of new β-lactams to the expanded-spectrum β-lactamase CTX-1Infection, 1989
- In vitro studies of BMY-28142, a new broad-spectrum cephalosporinAntimicrobial Agents and Chemotherapy, 1985